e-learning
resources
Munich 2014
Saturday, 06.09.2014
PG17 Lung cancer: the issue with the tissue
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How do we interpret the sample data?
A. Cortot (Lille, France)
Source:
International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Session:
PG17 Lung cancer: the issue with the tissue
Session type:
Postgraduate Course
Number:
145
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Cortot (Lille, France). How do we interpret the sample data?. International Congress 2014 – PG17 Lung cancer: the issue with the tissue
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
How do we interpret the results?
Source: Annual Congress 2006 - Blood gas workshop
Year: 2006
Analysing the data
Source: ERS Course 2015
Year: 2015
Neither questions nor answers, just original data
Source: Eur Respir J 2003; 21: 377
Year: 2003
How can real-world data be used to improve outcomes?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021
Application of big data technology for COVID-19: Primary care big data
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021
How to interpret microbiological results
Source: International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Year: 2014
How should tumour sample analysis be applied to patient management?
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014
A data management and analysis platform for RASP-UK multiomics clinical datasets
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021
More than just a study subject?
Source: Annual Congress 2013 –ELF/ERS “Effective engagement of patients and the public in science, healthcare and the media”
Year: 2013
Is data quality more important than data quantity in the diagnosis of occupational asthma from serial PEF records?
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010
How to use monitoring data to make wise clinical decisions
Source: International Congress 2015 – PG3 Cardiorespiratory monitoring in critically ill patients
Year: 2015
Defining successful NIV setup: data from a real-life cohort
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021
What have we learn from rebiospy studies?
Source: ERS Research Seminar
Year: 2015
Who do we exclude if we only consider subjects with excellent quality spirometry?Analysis of UK Biobank longitudinal data.
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing
Source: ERJ Open Res, 4 (1) 00108-2017; 10.1183/23120541.00108-2017
Year: 2018
What makes large epidemiological studies comparable?
Source: Eur Respir J 2010; 36: 720-721
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept